ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
Dow Jones
38.239,66
0,40%
Euro vs US Dollar
1,06965
0,00%
Bitcoin
63.915,96
0,80%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Adicet Bio Inc (ACET)

  7. Adicet Bio Inc (ACET) News

ACET Adicet Bio Inc

1,73
-0,08 (-4,42%)
27 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Adicet Bio Inc ACET NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
-0,08 -4,42% 1,73 06:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,81 1,66 1,825 1,68 1,81
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
22.4.202422:30BWAdicet Bio Highlights Preclinical Data Supporting IND..
08.4.202413:00BWAdicet Bio to Participate in 2024 Canaccord Genuity Horizons..
28.3.202422:19BWAdicet Bio Reports Inducement Grant under Nasdaq Listing..
19.3.202421:10BWAdicet Reports Fourth Quarter and Full Year 2023 Financial..
11.3.202412:00BWAdicet Bio to Participate in a Fireside Chat at the H.C...
01.3.202401:46BWAdicet Bio Reports Inducement Grant under Nasdaq Listing..
05.2.202422:01BWAdicet Bio to Participate in a Fireside Chat at the..
02.2.202417:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31.1.202422:39BWAdicet Bio Reports Inducement Grant under Nasdaq Listing..
27.1.202401:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.1.202401:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202422:01BWAdicet Bio, Inc. Announces Closing of $98 Million Public..
24.1.202422:34EDGAR2Form 8-K - Current report
24.1.202422:32EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23.1.202405:43BWAdicet Bio, Inc. Announces Pricing of Public Offering
22.1.202422:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22.1.202422:28BWAdicet Bio, Inc. Announces Proposed Public Offering
19.1.202422:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
16.1.202413:01EDGAR2Form 8-K - Current report
04.1.202413:17EDGAR2Form 8-K - Current report
04.1.202413:00BWAdicet Provides Corporate Update and Highlights Strategic..
03.1.202422:01BWAdicet Bio to Host Conference Call to Provide Updates on its..
29.12.202322:50BWAdicet Bio Reports Inducement Grant under Nasdaq Listing..
10.12.202318:00BWAdicet Bio Highlights ADI-001 Expansion, Persistence and..
13.11.202322:42EDGAR2Form 8-K - Current report
08.11.202322:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.11.202322:12EDGAR2Form 8-K - Current report
08.11.202322:10BWAdicet Reports Third Quarter 2023 Financial Results and..
07.11.202313:00BWAdicet Bio to Present at the 2023 Jefferies London..
02.11.202314:00BWAdicet Bio Announces Poster Presentation Highlighting..
31.10.202323:25BWAdicet Bio Reports Inducement Grant under Nasdaq Listing..
16.10.202322:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.10.202318:00BWAdicet Bio Announces Poster Presentation at the Upcoming..
03.10.202322:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.9.202323:24BWAdicet Bio Reports Inducement Grants under Nasdaq Listing..
27.9.202315:00BWAdicet Bio to Present Three Scientific Posters Highlighting..
31.8.202322:35BWAdicet Bio Reports Inducement Grants under Nasdaq Listing..
17.8.202300:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.8.202300:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.8.202300:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.8.202300:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.8.202300:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.8.202300:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.8.202322:27EDGAR2Form S-8 POS - Securities to be offered to employees in..
09.8.202322:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
09.8.202322:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.8.202322:17EDGAR2Form 8-K - Current report
09.8.202322:15BWAdicet Reports Second Quarter 2023 Financial Results and..
02.8.202322:00BWAdicet Bio to Participate in a Fireside Chat at the..
31.7.202322:50BWAdicet Bio Reports Inducement Grants under Nasdaq Listing..

Kürzlich von Ihnen besucht

NASDAQ
ACET
Adicet Bio
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten